Identifying Decision Making Needs for Older Adult Women With Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8
About this trial
This is an interventional supportive care trial for Anatomic Stage I Breast Cancer AJCC v8
Eligibility Criteria
INCLUSION CRITERIA:
Patient Inclusion Criteria
- Women aged 65 years or older
- Must write and speak English
- Must have been diagnosed with Stage I-III breast cancer
- Must have made decision to either receive or not receive neoadjuvant or adjuvant chemotherapy
- Must be within 3 months of breast cancer neoadjuvant or adjuvant chemotherapy treatment decision
- Self-reported no visual or auditory deficits
- SUBAIM 2b: Women aged 65 years or older
- SUBAIM 2b: Must write and speak English
- SUBAIM 2b: Must have been diagnosed with stage I-III breast cancer
- SUBAIM 2b: Must be a candidate for chemotherapy or targeted therapy (in the setting of HER2+ breast cancer)
- SUBAIM 2b: Must be making a decision regarding chemotherapy
- SUBAIM 2b: Self-reported no visual or auditory deficits
- PHYSICIAN INCLUSION CRITERIA
- Physician for patient recruited to participate in study (physician criteria)
Exclusion Criteria:
None
Sites / Locations
- M D Anderson Cancer CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Other
No Intervention
Intervention Arm
Non-Intervention Arm
Participants in the intervention arm only will then be asked to look at the decision tool that includes educational materials about the diagnosis and treatment of breast cancer. These could be written information, graphics, videos, animations, or questionnaires. This decision tool will personalize the decision to you specifically and support your decision-making process
Participants undergo interviews and complete questionnaires over 1-2 hours. Patients and physicians also participate in a discussion and complete shared decision-making questionnaire over 15-30 minutes.